Results 221 to 230 of about 527,852 (334)
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt +3 more
wiley +1 more source
Photoinactivation of influenza viruses by modulated indoor daylight spectrum and intensity. [PDF]
Zhao M +5 more
europepmc +1 more source
Hammering psychiatric practice: ECT gets a bad press [PDF]
Bertram Pitt
openalex +1 more source
Psychedelics, entactogens and psychoplastogens for depression and related disorders
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
Modified electroconvulsive therapy for perinatal depression: scoping review. [PDF]
Bobo WV +7 more
europepmc +1 more source
Urgent Need for Pairing Training and Education With Fentanyl Test Strip Distribution
ABSTRACT Introduction Fentanyl test strips (FTS) are increasingly recommended for non‐heroin drugs to detect potential fentanyl adulteration. The aim of this study was to better understand how people are using FTS. Methods In simulation exercises between September and October 2023, 40 people who used drugs participated in a mock use of FTS on a ...
Megan K. Reed +5 more
wiley +1 more source
Identification and Treatment of Catatonia Presenting as Agitation and Self Injury in an Adolescent With Rett Syndrome. [PDF]
Al-Omari A, Mohiuddin S.
europepmc +1 more source

